Search research articles
Contact Us
Filters
Showing results (1-10 of 59) with videos related to
Page
of 6
Sort By:
Journal of Clinical and Translational Science
|
November 29, 2023
Exercise as a community treatment for obesity and the metabolic disease epidemic
John Scholler, Jeffrey S Otis
Journal of Cancer Research and Clinical Oncology
|
May 26, 2020
Enhanced cytotoxicity against solid tumors by bispecific antibody-armed CD19 CAR T cells: a proof-of-concept study
Archana Thakur, John Scholler, Dana L Schalk, et al.
Biorxiv : the Preprint Server for Biology
|
August 6, 2025
Engineering a Juxtamembrane-Targeting CAR T-Cell Against Mesothelin: A Novel Binder Resilient to Shed Antigen in Ovarian and Pancreatic Cancer
John Scholler, Ai Song, Mansi Deshmukh, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
September 1, 2009
Externalization of the leaderless cytokine IL-1F6 occurs in response to lipopolysaccharide/ATP activation of transduced bone marrow macrophages
Unja Martin, John Scholler, Jesse Gurgel, et al.
Scientific Reports
|
February 7, 2024
ZFP36 disruption is insufficient to enhance the function of mesothelin-targeting human CAR-T cells
David Mai, Tifara Boyce, Aakash Mehta, et al.
Science Advances
|
January 11, 2023
Chimeric antigen receptor T cells as adjuvant therapy for unresectable adenocarcinoma
Ugur Uslu, Tong Da, Charles-Antoine Assenmacher, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 15, 2023
Combined disruption of T cell inflammatory regulators Regnase-1 and Roquin-1 enhances antitumor activity of engineered human T cells
David Mai, Omar Johnson, Jordan Reff, et al.
Cell Reports
|
September 28, 2017
Augmentation of Antitumor Immunity by Human and Mouse CAR T Cells Secreting IL-18
Biliang Hu, Jiangtao Ren, Yanping Luo, et al.
Frontiers in Immunology
|
July 22, 2021
Bispecific Antibody Armed Metabolically Enhanced Headless CAR T Cells
Archana Thakur, John Scholler, Ewa Kubicka, et al.
JCI Insight
|
June 17, 2020
A rational mouse model to detect on-target, off-tumor CAR T cell toxicity
Mauro Castellarin, Caroline Sands, Tong Da, et al.
Page
of 6
Search research articles
Search
Showing results (1-10 of 59) with videos related to
Sort By:
Page
of 6
Journal of Clinical and Translational Science
|
November 29, 2023
Exercise as a community treatment for obesity and the metabolic disease epidemic
John Scholler, Jeffrey S Otis
Journal of Cancer Research and Clinical Oncology
|
May 26, 2020
Enhanced cytotoxicity against solid tumors by bispecific antibody-armed CD19 CAR T cells: a proof-of-concept study
Archana Thakur, John Scholler, Dana L Schalk, et al.
Biorxiv : the Preprint Server for Biology
|
August 6, 2025
Engineering a Juxtamembrane-Targeting CAR T-Cell Against Mesothelin: A Novel Binder Resilient to Shed Antigen in Ovarian and Pancreatic Cancer
John Scholler, Ai Song, Mansi Deshmukh, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
September 1, 2009
Externalization of the leaderless cytokine IL-1F6 occurs in response to lipopolysaccharide/ATP activation of transduced bone marrow macrophages
Unja Martin, John Scholler, Jesse Gurgel, et al.
Scientific Reports
|
February 7, 2024
ZFP36 disruption is insufficient to enhance the function of mesothelin-targeting human CAR-T cells
David Mai, Tifara Boyce, Aakash Mehta, et al.
Science Advances
|
January 11, 2023
Chimeric antigen receptor T cells as adjuvant therapy for unresectable adenocarcinoma
Ugur Uslu, Tong Da, Charles-Antoine Assenmacher, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 15, 2023
Combined disruption of T cell inflammatory regulators Regnase-1 and Roquin-1 enhances antitumor activity of engineered human T cells
David Mai, Omar Johnson, Jordan Reff, et al.
Cell Reports
|
September 28, 2017
Augmentation of Antitumor Immunity by Human and Mouse CAR T Cells Secreting IL-18
Biliang Hu, Jiangtao Ren, Yanping Luo, et al.
Frontiers in Immunology
|
July 22, 2021
Bispecific Antibody Armed Metabolically Enhanced Headless CAR T Cells
Archana Thakur, John Scholler, Ewa Kubicka, et al.
JCI Insight
|
June 17, 2020
A rational mouse model to detect on-target, off-tumor CAR T cell toxicity
Mauro Castellarin, Caroline Sands, Tong Da, et al.
Page
of 6